RIBONUCLEOTIDE REDUCTASE AS A CHEMOTHERAPEUTIC TARGET

[41] STOECKLER JD, 1986, CANCER RES, V46, P1774

[42] STUDIES OF N-HYDROXY-N'-AMINOGUANIDINE DERIVATIVES BY N-15 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY AND AS RIBONUCLEOTIDE REDUCTASE INHIBITORS [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) : 1326 - 1329

[43] THELANDER L, 1980, J BIOL CHEM, V255, P7426

[44] REDUCTION OF RIBONUCLEOTIDES [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 : 133 - 158

[45] TSENG WC, 1982, MOL PHARMACOL, V21, P474

[46] Webb J.L., 1963, ENZYMES METABOL INH, V1, p[66, 488]

[47] WEBER G, 1983, CANCER RES, V43, P3466

[48] WECKBECKER G, 1987, CANCER RES, V47, P975

[49] WECKBECKER G, 1987, P AM ASSOC CANC RES, V28, P300

[50] WECKBECKER G, 1987, IN PRESS BIOCH PHARM

[41] STOECKLER JD, 1986, CANCER RES, V46, P1774

[42] STUDIES OF N-HYDROXY-N'-AMINOGUANIDINE DERIVATIVES BY N-15 NUCLEAR MAGNETIC-RESONANCE SPECTROSCOPY AND AS RIBONUCLEOTIDE REDUCTASE INHIBITORS [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (09) : 1326 - 1329

[43] THELANDER L, 1980, J BIOL CHEM, V255, P7426

[44] REDUCTION OF RIBONUCLEOTIDES [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1979, 48 : 133 - 158

[45] TSENG WC, 1982, MOL PHARMACOL, V21, P474

[46] Webb J.L., 1963, ENZYMES METABOL INH, V1, p[66, 488]

[47] WEBER G, 1983, CANCER RES, V43, P3466

[48] WECKBECKER G, 1987, CANCER RES, V47, P975

[49] WECKBECKER G, 1987, P AM ASSOC CANC RES, V28, P300

[50] WECKBECKER G, 1987, IN PRESS BIOCH PHARM